Literature DB >> 10798067

Dialysis therapy in end-stage renal disease.

A Kalia1.   

Abstract

The prognosis for children on dialysis has improved significantly in the past two decades. Much of this improvement can be attributed to the realization that adequate nutrition is a critical element of dialysis therapy and long-term morbidity and mortality in the dialysis population are closely linked to the nutritional state. Recommendations for nutritional intake have been formulated for infants and children with end-stage renal disease that take into account not only the metabolic derangement but also the effect of the dialysis treatment itself on the gain and loss of nutrients. In addition, the relationship between nutritional intake and the "dose" of dialysis is becoming clearer. Increasing experience in pediatric dialysis is enabling better selection of the mode of dialysis for children of different ages. The realization that the permeability of the peritoneal membrane is different from individual to individual has led to customized dialysis prescriptions with a consequent increase in the efficacy of peritoneal dialysis. When combined with improvements in therapy of medical complications of chronic renal failure, including the availability of synthetic erythropoetin++ and growth hormone and the management of renal osteodystrophy, dialysis is becoming a fully-functional tool in the management of children with end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10798067     DOI: 10.1007/bf02761216

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  38 in total

1.  Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.

Authors:  F Yalçinkaya; N Tümer; N Cakar; N Ozkaya
Journal:  Pediatr Nephrol       Date:  1997-06       Impact factor: 3.714

2.  Impaired development of oral-motor functions required for normal oral feeding as a consequence of tube feeding during infancy.

Authors:  R S Kamen
Journal:  Adv Perit Dial       Date:  1990

3.  The management of renal osteodystrophy.

Authors:  I B Salusky; W G Goodman
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Growth retardation in children with chronic renal disease: scope of the problem.

Authors:  G Rizzoni; M Broyer; G Guest; R Fine; M A Holliday
Journal:  Am J Kidney Dis       Date:  1986-04       Impact factor: 8.860

Review 5.  Nutrition and the dialysis prescription.

Authors:  G M Chertow; A Bullard; J M Lazarus
Journal:  Am J Nephrol       Date:  1996       Impact factor: 3.754

6.  Recombinant human growth hormone treatment in infants with chronic renal failure.

Authors:  H Maxwell; L Rees
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

7.  Protein losses during peritoneal dialysis.

Authors:  M J Blumenkrantz; G M Gahl; J D Kopple; A V Kamdar; M R Jones; M Kessel; J W Coburn
Journal:  Kidney Int       Date:  1981-04       Impact factor: 10.612

8.  Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.

Authors:  J R Ongkingco; E J Ruley; M E Turner; M R Fragale
Journal:  Am J Nephrol       Date:  1994       Impact factor: 3.754

Review 9.  Adequacy of continuous ambulatory peritoneal dialysis: morbidity and mortality in chronic peritoneal dialysis.

Authors:  B P Teehan; C R Schleifer; J Brown
Journal:  Am J Kidney Dis       Date:  1994-12       Impact factor: 8.860

Review 10.  Chronic dialysis in the infant less than 1 year of age.

Authors:  T E Bunchman
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.